Summary

This document provides an overview of acute coronary syndromes, encompassing ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina. It covers the spectrum of symptoms, diagnostic criteria, and management approaches for these conditions, including classifications of myocardial infarction and immediate management considerations.

Full Transcript

INTERNAL MEDICINE Acute Coronary Syndromes Acute Coronary The term acute coronary syndrome encompasses Syndrome the spectrum of symptoms and clinical findings with acute myocardial ischemia  Usually precipitated by acute thrombosis...

INTERNAL MEDICINE Acute Coronary Syndromes Acute Coronary The term acute coronary syndrome encompasses Syndrome the spectrum of symptoms and clinical findings with acute myocardial ischemia  Usually precipitated by acute thrombosis induced by a ruptured or eroded atherosclerotic coronary plaque (unstable plaque) and coronary thrombosis Spectrum of Acute Coronary Syndromes  ST Elevation MI (STEMI) o Complete blockage of a coronary artery o Specific ECG changes (significant ST-segment elevation in two contiguous leads o Often present with severe & prolonged chest pain (may radiate to arms/jaw/back), SOB, diaphoresis, N/V  Non ST Elevation MI (NSTEMI) o Partial blockage of a coronary artery o Nonspecific ECG changes (ST-segment depression, T-wave inversion, or no changes) o Symptoms similar to STEMI, may be less severe  Unstable angina (UA) o New onset angina, increasing angina, or angina at rest reflecting a significant disruption in coronary artery blood flow without evidence of myocardial necrosis Myocardial Myocardial Infarction is defined as a rise and/or fall of cardiac biomarkers PLUS one of: Infarction  Symptoms of ischemia  Development of pathologic Q waves on the ECG  New or presumed new ST changes on ECG or new LBBB  Identification of intracoronary thrombus by angiography or autopsy  Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality Classification of Myocardial Infarction  Type 1 MI- pathologic process in the wall of the coronary artery (plaque rupture, fissuring, dissection)  Type 2 MI- results from a critical imbalance between myocardial oxygen supply and demand (coronary spasm, anemia, arrhythmias, hypotension, hypertension, respiratory failure)  Type 3 MI- MI resulting in death for which cardiac enzymes are not available  Type 4 MI- MI related to PCI/stent thrombosis  Type 5 MI- MI related to CABG Approach to Differential Diagnosis Acute Chest Pain Immediate Management  Vitals including blood pressure in BOTH arms  Oxygen if hypoxic (SpO2 < 90%)  IV access  ECG within 10 minutes of medical contact  History & physical  CBC, electrolytes, BUN, Cr, troponin, and CK  CXR INTERNAL MEDICINE Acute Coronary Syndromes  Pain management (nitro, opioid) STEMI ST Elevation MI (STEMI)  Ischemic type chest pain  ECG compatible o ST elevation >2mm in 2+ contiguous leads (e.g., V2+V3, V5+V6, etc.) o New LBBB (left bundle branch block) STEMI Management  Primary goal is to open the infarct related artery as soon as possible to restore perfusion Revascularization  Mechanical  primary PCI  Pharmacological  fibrinolytic therapy  Surgical  CABG Primary PCI Fibrinolytic Therapy (e.g., Atleplase, Tenecteplase)  Better vessel patency  Risk of stroke (1.2%), intracranial hemorrhage (0.7%), with PCI (>90% major non-cerebral bleeding (1.8% severe bleeding, restoration of flow vs 55- 11.4% moderate bleeding) 60% with lytic)  Less recurrent Indications for Fibrinolysis ischemia/infarction with  Goal FMC to balloon time is not achievable PCI  Goal FMC to needle time

Use Quizgecko on...
Browser
Browser